Smith & Nephew expands uterine care portfolio with innovative diagnostic device
Smith & Nephew, the global medical technology business, today announces an agreement with Femasys Inc., the medical device developer of women’s healthcare solutions, to become the sole provider in the United States of Femasys’ FemVue® Saline-Air Device
read more...

New technology from Smith & Nephew offers more efficient uterine fibroid removal
Smith & Nephew (LSE:SN NYSE:SNN), the global medical technology business, today introduced the newest addition to its innovative TRUCLEAR™ System, the TRUCLEAR ULTRA Reciprocating Morcellator 4.0
Press Release – December 18, 2012
read more...

Favorable verdict in gynecology patent infringement suit
Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, announces that earlier this week,, a jury in the US District Court for Massachusetts (Boston) found that Hologic, Inc. (Bedford, Mass.) infringed two US Patents held by Smith & Nephew
read more...